FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96058005: Cilastatin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
159098019 Cilastatin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840341010 Cilastatin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
159098019 Cilastatin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
159098019 Cilastatin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840341010 Cilastatin (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
840341010 Cilastatin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
51251000195111 cilastatina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65471000195112 Cilastatin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
800761000172110 cilastatine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
800761000172110 cilastatine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
51251000195111 cilastatina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65471000195112 Cilastatin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilastatin Is a Medicinal product containing beta-lactam and acting as antibacterial agent (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a Fatty acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a Peptide hydrolase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Has disposition Peptide hydrolase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a Organic sulfide compound true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin Is a Drug or medicament (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Cilastatin- and imipenem-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Imipenem 500mg/cilastatin 500mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Imipenem 500mg/cilastatin 500mg powder for infusion solution transfer vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Imipenem 750mg/cilastatin 750mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Product containing cilastatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilastatin- and imipenem-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin sodium (substance) Is a False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has basis of strength substance (attribute) False Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilastatin sodium (substance) Is modification of (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only cilastatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cilastatin and imipenem (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin- and imipenem- and relebactam-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only cilastatin and imipenem and relebactam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 3
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 3
Cilastatin and imipenem and relebactam only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 3
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for suspension for injection vial Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance (attribute) True Cilastatin Inferred relationship Existential restriction modifier (core metadata concept) 2

Reference Sets

GB English

US English

Back to Start